Pfizer CEO Albert Bourla revealed on Monday morning that their vaccine against Omicron could be distributed as early as March.
“This vaccine will be ready in March. We (are) already starting manufacturing some of these quantities at risk,” Bourla said.
“The hope is that we will achieve something that will have way, way better protection particularly against infections, because the protection against the hospitalizations and the severe disease — it is reasonable right now, with the current vaccines, as long as you are having let’s say the third dose,” Bourla added.
Meanwhile, Bourla believes the fourth vaccine given to risk groups by the Israeli government is not needed anymore.
Bourla said more evidence is required to justify this initiative.
Sources said Israel has made the fourth dose of Pfizer and BioNTech’s vaccine available to people over the age of 60, people with compromised immune systems, and healthcare workers.
According to reports, Israel made the order since their study showed that a fourth dose of the vaccine increases antibodies that protect against the virus fivefold a week after receiving the shot.